BIOMERIEUX

Depending on the exchange, the stock ticker may vary. For instance, on TURQUOISE exchange BIOMERIEUX stocks are traded under the ticker BIMP.

BIOMERIEUX is going to release the next earnings report on Sep 4, 2024. Keep track of upcoming events with our Earnings Calendar.

BIMP earnings for the last quarter are 1.46 EUR per share, whereas the estimation was 1.61 EUR resulting in a −9.32% surprise. The estimated earnings for the next quarter are 1.87 EUR per share. See more details about BIOMERIEUX earnings.

BIOMERIEUX revenue for the last quarter amounts to ‪1.48 B‬ EUR despite the estimated figure of ‪1.56 B‬ EUR. In the next quarter revenue is expected to reach ‪1.44 B‬ EUR.

Yes, you can track BIOMERIEUX financials in yearly and quarterly reports right on TradingView.

BIMP net income for the last quarter is ‪196.00 M‬ EUR, while the quarter before that showed ‪161.60 M‬ EUR of net income which accounts for 21.29% change. Track more BIOMERIEUX financial stats to get the full picture.

BIOMERIEUX dividend yield was 0.84% in 2023, and payout ratio reached 28.08%. The year before the numbers were 0.87% and 22.16% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.

Like other stocks, BIMP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOMERIEUX stock right from TradingView charts — choose your broker and connect to your account.

BIMP reached its all-time high on Oct 14, 2020 with the price of 144.70 EUR, and its all-time low was 17.75 EUR and was reached on Dec 19, 2011.
See other stocks reaching their highest and lowest prices.

As of Apr 24, 2024, the company has ‪14.65 K‬ employees. See our rating of the largest employees — is BIOMERIEUX on this list?

We've gathered analysts' opinions on BIOMERIEUX future price: according to them, BIMP price has a max estimate of 128.00 EUR and a min estimate of 90.00 EUR. Read a more detailed BIOMERIEUX forecast: see what analysts think of BIOMERIEUX and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOMERIEUX EBITDA is ‪795.10 M‬ EUR, and current EBITDA margin is 21.64%. See more stats in BIOMERIEUX financial statements.